Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a long-term outcome benefit by Chierakul, W, Anunnatsiri, S, Chaowagul, W, Peacock, S, Chetchotisakd, P, Day, N

Increasing incidence of human melioidosis in Northeast Thailand. by Limmathurotsakul, D, Wongratanacheewin, S, Teerawattanasook, N, Wongsuvan, G, Chaisuksant, S, Chetchotisakd, P, Chaowagul, W, Day, N, Peacock, S

Consensus guidelines for dosing of amoxicillin-clavulanate in melioidosis. by Cheng, A, Chierakul, W, Chaowagul, W, Chetchotisakd, P, Limmathurotsakul, D, Dance, D, Peacock, S, Currie, B

Short report: Consensus guidelines for dosing of amoxicillin-clavulanate in melioidosis by Cheng, A, Chierakul, W, Chaowagul, W, Chetchotisakd, P, Limmathurotsakul, D, Dance, D, Peacock, S, Currie, B

Individualised, short-course antibiotic treatment versus usual long-course treatment for ventilator-associated pneumonia (REGARD-VAP): a multicentre, individually randomised, open-... by Mo, Y, Booraphun, S, Li, AY, Domthong, P, Kayastha, G, Lau, YH, Chetchotisakd, P, Limmathurotsakul, D, Tambyah, PA, Cooper, BS

Phenotypic and functional characterization of human memory T cell responses to Burkholderia pseudomallei by Tippayawat, P, Saenwongsa, W, Mahawantung, J, Suwannasaen, D, Chetchotisakd, P, Limmathurotsakul, D, Peacock, S, Felgner, P, Atkins, H, Titball, R, Bancroft, G, Lertmemongkolchai, G

Reducing antibiotic treatment duration for ventilator-associated pneumonia (REGARD-VAP): a trial protocol for a randomised clinical trial by Mo, Y, West, TE, MacLaren, G, Booraphun, S, Li, AY, Kayastha, G, Lau, YH, Chew, YT, Chetchotisakd, P, Tambyah, PA, Limmathurotsakul, D, Cooper, B

Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis. by Chierakul, W, Anunnatsiri, S, Short, J, Maharjan, B, Mootsikapun, P, Simpson, A, Limmathurotsakul, D, Cheng, A, Stepniewska, K, Newton, P, Chaowagul, W, White, N, Peacock, S, Day, N, Chetchotisakd, P

A comparison between 12 versus 20 weeks of trimethoprim-sulfamethoxazole as oral eradication treatment for melioidosis: an open-label, pragmatic, multicenter, non-inferiority, rand... by Anunnatsiri, S, Chaowagul, W, Teparrukkul, P, Chetchotisakd, P, Tanwisaid, K, Khemla, S, Narenpitak, S, Pattarapongsin, M, Kongsawasd, W, Pisuttimarn, P, Thipmontree, W, Mootsikapun, P, Chaisuksant, S, Chierakul, W, Day, NPJ, Limmathurotsakul, D

Trimethoprim-sulfamethoxazole versus trimethoprimsulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): A multicentre, double-blind, non-inferiori... by Chetchotisakd, P, Anunnatsiri, S, Mootsikapun, P, Wongrattanacheewin, S, Chierakul, W, Wuthiekanun, V, Chantratita, N, Thaipadungpanit, J, Day, N, Limmathurotsakul, D, Peacock, S, Chaowagul, W, Phimda, K, Phiphitaporn, S, Chaisuksant, S, Susaengrat, W, Pilaikul, J, Toondee, C, Thinkhamrop, B

Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferior... by Chetchotisakd, P, Chierakul, W, Chaowagul, W, Anunnatsiri, S, Phimda, K, Mootsikapun, P, Chaisuksant, S, Pilaikul, J, Thinkhamrop, B, Phiphitaporn, S, Susaengrat, W, Toondee, C, Wongrattanacheewin, S, Wuthiekanun, V, Chantratita, N, Thaipadungpanit, J, Day, N, Limmathurotsakul, D, Peacock, S

Trimethoprim-sulfamethoxazole versus trimethoprimsulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): A multicentre, double-blind, non-inferiori... by Chetchotisakd, P, Anunnatsiri, S, Mootsikapun, P, Wongrattanacheewin, S, Chierakul, W, Wuthiekanun, V, Chantratita, N, Thaipadungpanit, J, Day, N, Limmathurotsakul, D, Peacock, S, Chaowagul, W, Phimda, K, Phiphitaporn, S, Chaisuksant, S, Susaengrat, W, Pilaikul, J, Toondee, C, Thinkhamrop, B

Antibiotic susceptibility of clinical Burkholderia pseudomallei isolates in northeast Thailand during 2015-2018 and the genomic characterization of β-lactam-resistant isolates by Hii, SYF, Tandhavanant, S, Phunpang, R, Ekchariyawat, P, Saiprom, N, Chewapreecha, C, Seng, R, Thiansukhon, E, Morakot, C, Sangsa, N, Chayangsu, S, Chuananont, S, Tanwisaid, K, Silakun, W, Buasi, N, Chaisuksant, S, Hompleum, T, Chetchotisakd, P, Day, NPJ, Chantratita, W, Lertmemongkolchai, G, West, TE, Chantratita, N